Top compounds associated with response to TMBIM4


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.03 0.4
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.04 0.4
mRNA IC-87114 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA RAF265 CTRPv2 pan-cancer AAC -0.034 0.4
mRNA canertinib CTRPv2 pan-cancer AAC -0.03 0.4
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.029 0.4
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC 0.042 0.4
mRNA tandutinib CTRPv2 pan-cancer AAC 0.029 0.4
mRNA regorafenib CTRPv2 pan-cancer AAC 0.03 0.4
Download CSV